182 related articles for article (PubMed ID: 8446598)
1. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Wolf C; Rouyer N; Lutz Y; Adida C; Loriot M; Bellocq JP; Chambon P; Basset P
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1843-7. PubMed ID: 8446598
[TBL] [Abstract][Full Text] [Related]
2. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Basset P; Wolf C; Chambon P
Breast Cancer Res Treat; 1993; 24(3):185-93. PubMed ID: 8435474
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Basset P; Wolf C; Rouyer N; Bellocq JP; Rio MC; Chambon P
Cancer; 1994 Aug; 74(3 Suppl):1045-9. PubMed ID: 7518738
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
5. Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.
Hähnel E; Dawkins H; Robbins P; Hähnel R
Int J Cancer; 1994 Jul; 58(2):157-60. PubMed ID: 8026874
[TBL] [Abstract][Full Text] [Related]
6. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Muller D; Wolf C; Abecassis J; Millon R; Engelmann A; Bronner G; Rouyer N; Rio MC; Eber M; Methlin G
Cancer Res; 1993 Jan; 53(1):165-9. PubMed ID: 7677979
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Ahmad A; Hanby A; Dublin E; Poulsom R; Smith P; Barnes D; Rubens R; Anglard P; Hart I
Am J Pathol; 1998 Mar; 152(3):721-8. PubMed ID: 9502414
[TBL] [Abstract][Full Text] [Related]
8. Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Linder C; Engel G; Auer G; Strander H; Linder S
Breast Cancer Res Treat; 1997 Feb; 42(3):207-13. PubMed ID: 9065604
[TBL] [Abstract][Full Text] [Related]
9. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer.
Engel G; Heselmeyer K; Auer G; Bäckdahl M; Eriksson E; Linder S
Int J Cancer; 1994 Sep; 58(6):830-5. PubMed ID: 7927875
[TBL] [Abstract][Full Text] [Related]
10. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
Lefebvre O; Wolf C; Limacher JM; Hutin P; Wendling C; LeMeur M; Basset P; Rio MC
J Cell Biol; 1992 Nov; 119(4):997-1002. PubMed ID: 1429845
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Wolf C; Chenard MP; Durand de Grossouvre P; Bellocq JP; Chambon P; Basset P
J Invest Dermatol; 1992 Dec; 99(6):870-2. PubMed ID: 1469302
[TBL] [Abstract][Full Text] [Related]
12. Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
Wang CS; Têtu B
Int J Cancer; 2002 Jun; 99(6):792-9. PubMed ID: 12115479
[TBL] [Abstract][Full Text] [Related]
13. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
14. Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Kawami H; Yoshida K; Ohsaki A; Kuroi K; Nishiyama M; Toge T
Anticancer Res; 1993; 13(6A):2319-23. PubMed ID: 8297152
[TBL] [Abstract][Full Text] [Related]
15. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.
Porte H; Chastre E; Prevot S; Nordlinger B; Empereur S; Basset P; Chambon P; Gespach C
Int J Cancer; 1995 Feb; 64(1):70-5. PubMed ID: 7665251
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Ahmad A; Marshall JF; Basset P; Anglard P; Hart IR
Int J Cancer; 1997 Oct; 73(2):290-6. PubMed ID: 9335457
[TBL] [Abstract][Full Text] [Related]
18. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Santavicca M; Noel A; Chenard MP; Lutz Y; Stoll I; Segain JP; Rouyer N; Rio MC; Wolf C; Belloco JP
Int J Cancer; 1995 Oct; 64(5):336-41. PubMed ID: 7591307
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.
Têtu B; Brisson J; Lapointe H; Bernard P
Hum Pathol; 1998 Sep; 29(9):979-85. PubMed ID: 9744315
[TBL] [Abstract][Full Text] [Related]
20. Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Pacheco MM; Mourão M; Mantovani EB; Nishimoto IN; Brentani MM
Clin Exp Metastasis; 1998 Oct; 16(7):577-85. PubMed ID: 9932604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]